Anagnostics Bioanalysis

We specialize in developing systems and tests for research and clinical in-vitro diagnostic procedures. Our aim is to provide solutions for unmet needs, especially in the fields of multiplexed protein and nucleic acid analysis.
Since 2005 our ambitious team around molecular geneticist Dr. Bernhard Ronacher develops a new multiplex assay and diagnostics technology. A cylindrical microarray, the patented hybcell, is the core of our technology.
Our vision is to establish hybcell technology in pharmaceutical research and clinical diagnostics.
Some of the benefits of our multiplex technology are the following:
- Precise, quick and cost-effective results
- Highly flexible assay design
- The possibility to measure kinetics
- Fully automated assay procedure
- Unprecedented ease of use for microarray assays
Reviews
No reviews to display
Latest news
News
Anagnostics Partnership Announced for Rapid Identification of Sepsis
06 Jul 2012
-
Ramcon A/S (Denmark) distributes and supports Anagnostics Products for Drugs of Abuse, Pharmacogenetic and Severe Infection Testing
15 Apr 2012
-
Revolutionary hybcell Technology for Fast & Sensitive KRAS Testing
09 Mar 2012
-
Anagnostics Hybcell Technology to be used for Drug Development
09 Feb 2012
-
Anagnostics Announces European Collaboration with Sony DADC
25 Nov 2011
Application articles
-
hybcell DoA Urine plexB-1-02 for Drug Screening
Anagnostics Bioanalysis01 May 2012
-
hybcell DoA Saliva plexB-1-02 for Drug Screening
Anagnostics Bioanalysis30 Apr 2012
-
Hybcode PCR Technology for Rapid C. Diff Detection
Anagnostics Bioanalysis17 Feb 2012
-
Compact Sequencing Technology for KRAS Companion Diagnostic Testing
Anagnostics Bioanalysis17 Feb 2012
-
Highly Specific Detection of Bacteria and Fungi with Hybcell compact-sequencing
Anagnostics Bioanalysis17 Feb 2012


